Onconic Therapeutics Inc. (KOSDAQ: A476060)
Health Care · Biotechnology · KR
₩13,900.00
-6.52% today · -23.7% 1Y
Onconic Therapeutics Inc. (KOSDAQ: A476060) operates in the Biotechnology industry within the Health Care sector. The company is valued at $473.42M.
Over the last twelve months the share price has lost 23.7%, trading between 8.79K and 28.90K.
Tweenvest scores Onconic Therapeutics Inc. across four factors: quality 68/100, value 54/100. Its strongest factor is quality.
A476060 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $473.42M
- Revenue (TTM)
- $53.06M
- P/E
- 26.30
- EPS
- 528.52
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩28,900.00
- 52-week low
- ₩8,790.00
- Avg volume (3M)
- —
- Shares outstanding
- 45.41M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Landfar Bio-medicine Co., LtdSZSE: 000504 | $481.38M | CN¥9.76 | -17.22% |
| TransThera Sciences (Nanjing), Inc.SEHK: 2617 | $481.33M | HK$9.28 | -11.07% |
| Steminent Biotherapeutics Inc.TPEX: 7729 | $479.33M | NT$193.00 | +0.78% |
| Thalys Medical Technology Group CorporationSHSE: 603716 | $477.36M | CN¥14.40 | -12.57% |
| Genfit S.A.ENXTPA: GNFT | $472.79M | €8.40 | +1.45% |
| Gongwin Biopharm Holdings Co., Ltd.TPEX: 6617 | $472.24M | NT$126.50 | +6.30% |
| Neurogene Inc.NasdaqGM: NGNE | $471.27M | $23.55 | -3.01% |
| Beijing Leadman Biochemistry Co.,Ltd.SZSE: 300289 | $469.93M | CN¥5.78 | -5.56% |
Figures last refreshed Oct 18, 2026.